What Is the New RSV Immunization for Infants?

• 2023

  Log in to bookmark this resource.

  Log in
• Stephen Eppes

---

Access Resources

• LectureEN
• Ask aRCie About This Resource

About

This short video discusses a new FDA-approved product that prevents serious RSV disease in children. It's not a typical vaccine but a monoclonal antibody given as a shot. This provides longer-lasting protection compared to older versions. Monoclonal antibodies for RSV have been used for over two decades, mainly in high-risk infants. While some may be hesitant about this new product, it's an improved version offering better protection for more infants.

---

Tags

Focus Area: Infectious Disease

Audiences: Families & Children; Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Immunization; Infant; Lung Diseases; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Premature Birth; Antibodies, Monoclonal, Humanized

Institutions: Christiana Care Health System

---

More like this

Vaccine Education Center None · Children's Hospital of Philadelphia Respiratory Infection Surge Sounds a Wake-Up Call for Pediatric Emergency Care 2022 · Yale New Haven Health System, Yale University Disparities in the Availability and Acceptance of Nirsevimab in Massachusetts 2024 · Harvard Medical School, Boston Children's Hospital

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---